Page last updated: 2024-08-23

paclitaxel and Acute Promyelocytic Leukemia

paclitaxel has been researched along with Acute Promyelocytic Leukemia in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	2 (18.18)	18.2507
2000's	3 (27.27)	29.6817
2010's	3 (27.27)	24.3611
2020's	2 (18.18)	2.80

Authors

Authors	Studies
Bittencourt, R; Coelho-Silva, JL; Costa-Lotufo, LV; de Figueiredo-Pontes, LL; de Melo, RA; Fagundes, EM; Kerbauy, F; Koury, LC; Lima, K; Lipreri da Silva, JC; Lucena-Araujo, AR; Machado-Neto, JA; Nunes, E; Pagnano, K; Pereira-Martins, DA; Rego, EM; Scheucher, PS; Traina, F; Vicari, HP	1
Feng, N; Guo, T; Hou, X; Li, Z; Liu, W; Xia, Q; Zhang, Y; Zhu, C	1
Asik, A; Balcı Okcanoglu, T; Biray Avci, C; Dogan Sigva, ZO; Gunduz, C; Kayabasi, C; Ozmen Yelken, B; Saydam, G; Yılmaz Susluer, S	1
Beil, M; Bruel, A; Guck, J; Lautenschläger, F; Paschke, S; Schinkinger, S	1
da Silva, J; Guck, JR; Lautenschläger, F; Sivaniah, E	1
Chan, A; Miller, JH; Rawson, P; William Jordan, T; Wilmes, A	1
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR	1
Bhalla, K; Huang, Y; Kumar, G; Ray, S; Self, S; Walle, T; Willingham, M	1
Davey, MW; Davey, RA; Mote, PA; Oliver, L	1
Cohen, MH; Flamm Honig, S; Hirschfeld, S; Ibrahim, A; Johnson, JR; O'Leary, JJ; Pazdur, R; White, RM; Williams, GA	1
Allison, DC; Donehower, RC; Roberts, JR; Robertson, J; Rowinsky, EK	1

Reviews

1 review(s) available for paclitaxel and Acute Promyelocytic Leukemia

Article	Year
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone marrow transplantation, 2003, Volume: 32, Issue:12 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous	2003

Article

Year

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.

Bone marrow transplantation, 2003, Volume: 32, Issue:12

Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous

2003

Other Studies

10 other study(ies) available for paclitaxel and Acute Promyelocytic Leukemia

Article	Year
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells. Investigational new drugs, 2022, Volume: 40, Issue:2 Topics: Cell Differentiation; Cell Proliferation; Humans; Leukemia, Promyelocytic, Acute; Mitosis; Oncogene Proteins, Fusion; Paclitaxel; Stathmin	2022
Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. International journal of pharmaceutics, 2020, Aug-30, Volume: 586 Topics: Abietanes; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Folic Acid; Humans; Leukemia, Promyelocytic, Acute; Lipid Bilayers; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Silicon Dioxide; Xenograft Model Antitumor Assays	2020
Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line. Gene, 2018, Mar-20, Volume: 647 Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Drug Therapy, Combination; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Metformin; NF-kappa B; Oxides; Paclitaxel; Signal Transduction	2018
The regulatory role of cell mechanics for migration of differentiating myeloid cells. Proceedings of the National Academy of Sciences of the United States of America, 2009, Sep-15, Volume: 106, Issue:37 Topics: Actin Cytoskeleton; Biomechanical Phenomena; Biophysical Phenomena; Cell Differentiation; Cell Line, Tumor; Cell Movement; Compliance; Humans; Leukemia, Promyelocytic, Acute; Microfluidic Analytical Techniques; Microtubules; Myeloid Cells; Paclitaxel; Tretinoin; Tubulin Modulators	2009
The cavity-to-cavity migration of leukaemic cells through 3D honey-combed hydrogels with adjustable internal dimension and stiffness. Biomaterials, 2010, Volume: 31, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Movement; Elasticity; Humans; Hydrogels; Leukemia, Promyelocytic, Acute; Materials Testing; Paclitaxel; Porosity; Tissue Scaffolds; Tretinoin; Tumor Cells, Cultured	2010
Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A. Investigational new drugs, 2012, Volume: 30, Issue:1 Topics: Antineoplastic Agents; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Down-Regulation; G2 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Lactones; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Paclitaxel; Proteomics; Proto-Oncogene Proteins c-myc; Two-Dimensional Difference Gel Electrophoresis	2012
Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2 Topics: Apoptosis; Cell Division; Cell Line; Cell Survival; Cell-Free System; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Microtubules; Mitosis; Nucleosomes; Paclitaxel; Taxoids; Tumor Cells, Cultured; Tumor Stem Cell Assay	1995
Paclitaxel sensitizes multidrug resistant cells to radiation. Anti-cancer drugs, 1996, Volume: 7, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Death; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Paclitaxel; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured; Verapamil	1996
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene. The oncologist, 2001, Volume: 6, Issue:1 Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Bexarotene; Breast Neoplasms; Drug Approval; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, T-Cell, Cutaneous; Nitriles; Oxides; Paclitaxel; Tamoxifen; Tetrahydronaphthalenes; Triazoles; United States; United States Food and Drug Administration	2001
Demonstration of the cell cycle positions of taxol-induced "asters" and "bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1989, Volume: 37, Issue:11 Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Autoradiography; Cell Cycle; Cell Line; DNA; Drug Resistance; Fluorescent Antibody Technique; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Microtubules; Mitosis; Paclitaxel; Thymidine; Tubulin	1989